INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $180,000 | +181.2% | 38,723 | +108.9% | 0.00% | – |
| Q4 2018 | $64,000 | -82.1% | 18,535 | -47.7% | 0.00% | – |
| Q3 2018 | $358,000 | +114.4% | 35,436 | +53.0% | 0.00% | – |
| Q2 2018 | $167,000 | +7.1% | 23,167 | -9.9% | 0.00% | – |
| Q1 2018 | $156,000 | -21.2% | 25,711 | +24.5% | 0.00% | – |
| Q4 2017 | $198,000 | -5.3% | 20,659 | -12.0% | 0.00% | – |
| Q3 2017 | $209,000 | -49.6% | 23,469 | -28.4% | 0.00% | – |
| Q2 2017 | $415,000 | -16.8% | 32,796 | -31.1% | 0.00% | – |
| Q1 2017 | $499,000 | -57.9% | 47,567 | -63.2% | 0.00% | -100.0% |
| Q4 2016 | $1,186,000 | +42.2% | 129,114 | +82.5% | 0.00% | – |
| Q3 2016 | $834,000 | +82.9% | 70,750 | +100.9% | 0.00% | – |
| Q2 2016 | $456,000 | -47.8% | 35,211 | -35.5% | 0.00% | – |
| Q1 2016 | $873,000 | -39.2% | 54,620 | +9.0% | 0.00% | -100.0% |
| Q4 2015 | $1,435,000 | +59.3% | 50,123 | +58.4% | 0.00% | 0.0% |
| Q3 2015 | $901,000 | +0.8% | 31,645 | +27.1% | 0.00% | 0.0% |
| Q2 2015 | $894,000 | +21.6% | 24,893 | +97.0% | 0.00% | 0.0% |
| Q1 2015 | $735,000 | +15.4% | 12,639 | -16.3% | 0.00% | 0.0% |
| Q4 2014 | $637,000 | +76.0% | 15,104 | +62.0% | 0.00% | – |
| Q3 2014 | $362,000 | +782.9% | 9,326 | +616.3% | 0.00% | – |
| Q2 2014 | $41,000 | -72.3% | 1,302 | -63.6% | 0.00% | – |
| Q1 2014 | $148,000 | +23.3% | 3,581 | +15.6% | 0.00% | – |
| Q4 2013 | $120,000 | – | 3,098 | +38625.0% | 0.00% | – |
| Q3 2013 | $0 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |